Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2026-2027)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Molecular Diagnostics for STD Market
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of sexually transmitted infections
- Increasing screening programs by the government
- Transition from conventional diagnostics to molecular techniques
- Growing emphasis on high-sensitivity and early-stage detection
- Supportive public health policies and funding initiatives
- Restraints
- Relatively high cost of molecular diagnostic tests and instruments
- Limited accessibility in low-resource and rural healthcare settings
- Complex and evolving regulatory approval requirements across regions
- Opportunities
- Integration with digital health ecosystems and telemedicine platforms
- Development of low-cost molecular assays to improve affordability
- Untapped potential in emerging and underserved markets
- Growing demand for assays that can detect multiple pathogens simultaul>
- Key Market Trends
- Rising adoption of automated and high-throughput laboratory systems
- Increasing use of self-collection and non-invasive sampling methods
- Unmet Market Needs
- Industry Speaks
- Drivers
- Global Molecular Diagnostics for STD Market Size & Forecast (2024-2031), By Product, USD Billion
- Introduction
- Instruments
- Consumables (Reagents and kits)
- Software & Services
- Market Dynamics
- Introduction
- CT/NG Testing
- Syphilis Testing
- Gonorrhoea Testing
- HSV Testing
- HPV Testing
- HIV Testing
- Trichomonas
- Ureaplasma + Mycoplasma
- Others
- Introduction
- Laboratory Testing
- Commercial/Private Labs
- Public Health Labs
- PoC Testing
- Global Molecular Diagnostics for STD Market Size & Forecast (2024-2031), By End User, USD Billion
- Introduction
- Hospitals
- Diagnostic Laboratories
- Clinics
- Home Settings
- Others
- Introduction
- North America Molecular Diagnostics for STD Market Size & Forecast (2024-2031), By Country, USD Billion
- US
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Canada
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Europe Molecular Diagnostics for STD Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- US
- Germany
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- France
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Italy
- Market Size & Forecast, By Product (USD Billion)ecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Spain
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Europe
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Asia Pacific (APAC) Molecular Diagnostics for STD Market Size & Forecast (2024-2031), By Country, USD Billion
- China
- Market Size & Forecast, By Product (USD Billion)
- Markde of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Japan
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- India
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)kTAM) Molecular Diagnostics for STD Market Size & Forecast (2024-2031), USD Billion
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
- Middle East & Africa (MEA) Molecular Diagnostics for STD Market Size & Forecast (2024-2031), USD Billion
- Market Size & Forecast, By Product (USD Billion)
- Market Size & Forecast, By Application (USD Billion)
- Market Size & Forecast, By Mode of Testing (USD Billion)
- Market Size & Forecast, By End User (USD Billion)
"10">
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2025)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2023-2026)
- New Product & Service Launch
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles
- BD (Becton, Dickinson and Company)
- Hoffmann-La Roche Ltd
- Hologic Inc.
- Abbott Laboratories
- Cepheid (Danaher Corporation)
- Qiagen N.V.
- bioMrieux SA
- Thermo Fisher Scientific, Inc.
- Seegene Inc.
- DiaSorin S.p.A
- Other Prominent Players
(Business Overview, Financial Performance, Products Offered, Recent Developments)
- China